Entering text into the input field will update the search result below

Week 10 Breakout Forecast: Short-Term Picks To Give You An Edge



  • Publishing two of the 8 new Week 10 breakout stocks that are available only to subscribers with better than 10% short-term upside potential.
  • Performance Results for both 1-week and 2-week holding periods are significantly outperforming S&P 500 YTD with 1-week YTD +14.68% and most recent 2-week holding period +9.83%.
  • Top Gainers thru Week 9: ARWR +14.83% VCEL +14.38% / Week 8: FATE +52% DRNA +29.2% / Week 7: EGAN +36.60% FEYE +13.79% EROS +10.83% / Week 6: CCXI +12.60%.
  • The streak of breakout stocks gaining greater than 10% in less than 5 trading days continues through 3 straight weeks with ARWR +14.83% and VCEL +14.38%.
  • Continuing from last year now makes it 43 out of 49 trading weeks (87.8%) with at least one stock move 10% or greater within a 4 or 5 day trading week.

Breakout Forecast Selections for Week 10:

Market conditions continue with extreme volatility. Readers are cautioned that negative conditions are still strong and my momentum gauge remains the same as the prior week 9 at a value of 35. Volatility in the market is at all time highs with this past week having 4 out of 5 days with greater than 1% moves in the S&P 500. In contrast to this time last year the market had gone 81 days without a single 1% daily move.

My momentum gauge is based on the size of the list of positive and negative screened momentum stocks. The negative momentum indicator has increased from 35 last week to 42 this week. The positive momentum indicator has remained the same from last week at 35. The all time low for positive momentum selections is 10 (during week 6) and all time high is 120 (last August).

Additional selections from last week's separate technical articles continue to deliver strong double-digit returns: AGEN +29.88% and DRNA +26.52%

This week I have selected 8 breakout stocks from the following sectors: 7 healthcare and 1 technology. I continue to see strong signals of breakouts across the biotech sector as I described in my last sector report.

** I also want to mention that subscribers to my stock service have again put me on the Seeking Alpha list as one of the top authors for the month for the second month in a row. I hope you will also consider joining for more valuable updates in Value & Momentum Breakouts.

The two new selections of positive momentum stocks for this week include:

  1. ChemoCentryx (CCXI) - Healthcare / Biotechnology
  2. Infinity Pharmaceuticals (INFI) - Healthcare / Biotechnology

This article was written by

JD Henning profile picture

JD Henning is a Finance PhD, MBA, investment adviser, fraud examiner and certified anti-money laundering specialist with more than 30 years trading and investing stocks and other securities. JD runs Value & Momentum Breakouts where he identifies identify breakout signals and breakdown warnings using technical and fundamental analysis.

Signals from his proprietary Momentum Gauges® not only alert subscribers of market changes, but the strength of markets for short term breakouts or breakdown warnings across 11 different sectors. Top stock and ETF selections use technical and fundamental systems in proven financial studies. Value & Momentum Breakouts is the place to build your own optimal portfolio mix with a community of like-minded investors and traders. Features include a Premium Portfolio, bull/bear ETF strategy, morning updates and an active chat room. Learn more.

Analyst’s Disclosure: I am/we are long VCEL, ARWR, FBIO, CDXS, DRNA, FATE, FEYE, EROS, EGAN, CCXI. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

Comments (23)

sbrncra profile picture
Anything opinion on SENS? FDA review March 29!!!
JD Henning profile picture
Portfolio finished the week +14.99%

3 stocks finished the week above 15% one above 67%
JD Henning profile picture
CCXI up over +14% so far today, INFI +13% since Monday.

Selection for members up: +66.62%, +6.37%, +3.88% and portfolio up over 13% for the week through early Friday morning.
JD what are your thoughts on XPLR, RUN & SND. Made some appreciable gains on SES THANKS!
JD Henning profile picture

Glad to hear that! I do provide stock reviews and analysis on a daily basis but is for members only as part of their exclusive value as subscribers.
JD Henning profile picture
Portfolio is up +10.82% through Tuesday.
Triple bottom on CLDX, this stock can bounce back to 3 bucks no problem, back up the truck...
Great day on INFI, target 5 bucks!
Yes but robotics are a safe harbor for investing as it’s purely the wave of the future in medicine
Look at HAIR numbers. Big growth opportunity for any one looking to hit one out of the park
JD Henning profile picture
HAIR was a prior breakout stock this year. You should take a look at the current list.

Today INFI closed +31.40% and another stock for members gained 32.10%
JD Henning profile picture
So far Breakout Stock selections have 3 of 5 top spots on the biggest Nasdaq gainers today, including INFI +13%.
JD Henning profile picture
Week 10 keeps the streak of 10% gainers going early this week, with one stock for members up over 60% this morning.
Main Street Origin Investments profile picture
Defiantly been tough hold, played SRPT at same time, had similar profiles, left SRPT to early of course & didn’t bother grabbing when fill to $8 after grabbing at $13, mini biotech’s make great fish stories, usually leave just before breakout cause they can frustrate, CLDX story supposed to make or break over next 1.5 years, many feel risk turns to upside in next couple years, but no doubt, painful ride down, still holding at $3.54 cost avg.
Main Street Origin Investments profile picture
Have FEYE, SGYP or CLDX made list recently. EBIX higher priced stock with nice 5 year run, but consolidated after another amazing quarter, really curious about SGYP, with limit buy close to $1.68-$1.73 lows with willingness to meet half way at $2.13, already been accumulating CLDX last couple years when fell under $5
TruffelPig profile picture
CLDX? I am long this thing but it is not really doing much. No momentum really. 80% sell on barchart: http://bit.ly/2Ff0iwe
JD Henning profile picture
FEYE was a Week 7 pick this year and is up 13.79% since then. I don't think SGYP or EBIX has yet been selected. CLDX has not been selected this year but was a breakout selection for a short period last year.
Have owned EBIX for about 7-8 years and it was tough going for about the first 4 years bc of the incessant short attacks though I still believed. After the shorties finally gave up it has done very well and I plan on holding long term and expect good things well into the future unless fundamentals or competition changes. Who knows, maybe Amazon will enter that arena since there does not seem to be anything Bezos thinks he can't do, and do better than anyone else :)
Disagree with this article? Submit your own. To report a factual error in this article, . Your feedback matters to us!

Related Stocks

SymbolLast Price% Chg
Arrowhead Pharmaceuticals, Inc.
Amgen Inc.
Codexis, Inc.
Histogen Inc.
Cryoport, Inc.

Related Analysis

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.